{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:25Z","timestamp":1786120225451,"version":"build-2736575974"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,28]]},"DOI":"10.1097\/qad.0b013e32834f324b","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T06:19:19Z","timestamp":1323325159000},"page":"253-262","source":"Crossref","is-referenced-by-count":50,"title":["Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients"],"prefix":"10.1097","volume":"26","author":[{"given":"Kathryn","family":"Childs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Welz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Samarawickrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-1-20210130","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/00002030-200208160-00012","article-title":"Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study.","volume":"16","author":"Mocroft","year":"2002","journal-title":"AIDS"},{"key":"R3-1-20210130","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review.","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"R4-1-20210130","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/QAD.0b013e32833c3281","article-title":"Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase.","volume":"24","author":"Welz","year":"2010","journal-title":"AIDS"},{"key":"R5-1-20210130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cid\/ciq158","article-title":"Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population.","volume":"52","author":"Dao","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R6-1-20210130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/QAI.0b013e31821ae418","article-title":"Vitamin D deficiency in HIV-infected and un-infected women in the US.","volume":"57","author":"Adeyemi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-1-20210130","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.","volume":"93","author":"Triant","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-1-20210130","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/cid\/ciq242","article-title":"Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.","volume":"52","author":"Young","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R9-1-20210130","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin d deficiency: an endocrine society clinical practice guideline.","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-1-20210130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency.","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"R11-1-20210130","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/QAD.0b013e3283474ef9","article-title":"Vitamin D deficiency is less common among HIV-infected African-American men than in a matched cohort.","volume":"25","author":"Ormesher","year":"2011","journal-title":"AIDS"},{"key":"R12-1-20210130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00198-010-1299-x","article-title":"Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women.","volume":"22","author":"Stein","year":"2011","journal-title":"Osteoporos Int"},{"key":"R13-1-20210130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10067-005-0028-x","article-title":"Abnormalities in the bone mineral metabolism in HIV-infected patients.","volume":"25","author":"Garcia Aparicio","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R14-1-20210130","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/ajcn\/83.5.1135","article-title":"Vitamin D status in adolescents and young adults with HIV infection.","volume":"83","author":"Stephensen","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"R15-1-20210130","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ajcn\/67.6.1232","article-title":"Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women.","volume":"67","author":"Harris","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"R16-1-20210130","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/QAD.0b013e328337b161","article-title":"High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients.","volume":"24","author":"Mueller","year":"2010","journal-title":"AIDS"},{"key":"R17-1-20210130","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/QAI.0b013e3181caebaa","article-title":"Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency.","volume":"54","author":"Rosenvinge","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R18-1-20210130","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/QAD.0b013e328347f6f7","article-title":"Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study.","volume":"25","author":"Viard","year":"2011","journal-title":"AIDS"},{"key":"R20-1-20210130","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1089\/aid.2008.0058","article-title":"Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy.","volume":"24","author":"Van Den Bout-Van Den Beukel","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R21-1-20210130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/aid.2008.0183","article-title":"High frequency of vitamin D deficiency in ambulatory HIV-Positive patients.","volume":"25","author":"Rodriguez","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R22-1-20210130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/QAD.0b013e32834542fa","article-title":"Vitamin D deficiency in HIV infected patients: associated with NNRTI or efavirenz use.","volume":"25","author":"Pasquet","year":"2011","journal-title":"AIDS"},{"key":"R23-1-20210130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3851\/IMP1502","article-title":"Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D.","volume":"15","author":"Brown","year":"2010","journal-title":"Antivir Ther"},{"key":"R24-1-20210130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-6405-7-40","article-title":"Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen.","volume":"7","author":"Conesa-Botella","year":"2010","journal-title":"AIDS Res Ther"},{"key":"R25-1-20210130","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1089\/aid.2009.0063","article-title":"No influence of nevirapine on vitamin D deficiency in HIV-infected patients.","volume":"25","author":"Lattuada","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R26-1-20210130","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/QAD.0b013e32834544af","article-title":"Is lower serum 25-hydroxy vitamin D associated with efavirenz or the nonnucleoside reverse transcriptase inhibitor class.","volume":"25","author":"Fux","year":"2011","journal-title":"AIDS"},{"key":"R27-1-20210130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/aid.2010.0081","article-title":"Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial.","volume":"27","author":"Fox","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R28-1-20210130","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/QAD.0b013e32832c4947","article-title":"First line zidovudinelamivudinelopinavirritonavir leads to greater bone loss compared to nevirapinelopinavirritonavir.","volume":"23","author":"van Vonderen","year":"2009","journal-title":"AIDS"},{"key":"R29-1-20210130","first-page":"A42","article-title":"Analysis of vitamin D and parathyroid hormone in the SENSE trial: etravirine versus efavirenz in treatment-naive HIV-1 infected patients.","volume":"15","author":"Rockstroh","year":"2010","journal-title":"Antiviral Therapy"},{"key":"R31-1-20210130","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/QAD.0b013e3283454461","article-title":"Do nevirapine and efavirenz affect vitamin D homeostasis similarly.","volume":"25","author":"Welz","year":"2011","journal-title":"AIDS"},{"key":"R32-1-20210130","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1124\/mol.108.053660","article-title":"Regulation of human vitamin D(3) 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells.","volume":"75","author":"Ellfolk","year":"2009","journal-title":"Mol Pharmacol"},{"key":"R33-1-20210130","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1073\/pnas.0402490101","article-title":"Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase.","volume":"101","author":"Cheng","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R34-1-20210130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI21867","article-title":"Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia.","volume":"115","author":"Pascussi","year":"2005","journal-title":"J Clin Invest"},{"key":"R35-1-20210130","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1002\/ijc.23197","article-title":"Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma.","volume":"122","author":"Landriscina","year":"2008","journal-title":"Int J Cancer"},{"key":"R36-1-20210130","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1089\/aid.2005.21.915","article-title":"Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy.","volume":"21","author":"Ramayo","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R37-1-20210130","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/QAD.0b013e328349060e","article-title":"Secondary hyperparathyroidism in HIV patients: is there any responsibility of highly active antiretroviral therapy.","volume":"25","author":"Daria","year":"2011","journal-title":"AIDS"},{"key":"R38-1-20210130","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/aid.2009.0308","article-title":"Short communication: inadequate vitamin d exacerbates parathyroid hormone elevations in tenofovir users.","volume":"26","author":"Childs","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R40-1-20210130","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/QAD.0b013e3283262a64","article-title":"Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.","volume":"23","author":"Labarga","year":"2009","journal-title":"AIDS"},{"key":"R41-1-20210130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/00365540903463981","article-title":"Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study.","volume":"42","author":"Bang","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"R42-1-20210130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/QAI.0b013e3181bf6471","article-title":"Short-term bone loss in HIV-infected premenopausal women.","volume":"53","author":"Yin","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R43-1-20210130","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1177\/135965350801300803","article-title":"Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study.","volume":"13","author":"Fux","year":"2008","journal-title":"Antivir Ther"},{"key":"R44-1-20210130","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/644769","article-title":"Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-lamivudine: a randomized, 96-week trial.","volume":"49","author":"Martin","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R45-1-20210130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/QAI.0b013e31820cf010","article-title":"Markers of bone turnover are elevated in patients with antiretroviral treatment independent of the substance used.","volume":"56","author":"Piso","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R46-1-20210130","first-page":"39","article-title":"Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.","volume":"48","author":"Madeddu","year":"2004","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R47-1-20210130","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1086\/644785","article-title":"Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.","volume":"200","author":"Calmy","year":"2009","journal-title":"J Infect Dis"},{"key":"R48-1-20210130","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","article-title":"Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.","volume":"17","author":"Bruera","year":"2003","journal-title":"AIDS"},{"key":"R49-1-20210130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/656417","article-title":"Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.","volume":"51","author":"Stellbrink","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R51-1-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QCO.0b013e328334fe9a","article-title":"HIV and bone mineral density.","volume":"23","author":"Mallon","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"R52-1-20210130","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00198-005-1845-0","article-title":"Bone mass and mineral metabolism in HIV postmenopausal women.","volume":"16","author":"Yin","year":"2005","journal-title":"Osteoporos Int"},{"key":"R53-1-20210130","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1210\/jc.2006-0127","article-title":"Longitudinal analysis of bone density in human immunodeficiency virus-infected women.","volume":"91","author":"Dolan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-1-20210130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QAI.0b013e3181893e8e","article-title":"Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study.","volume":"49","author":"Jacobson","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R55-1-20210130","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1097\/QAD.0b013e328340a28d","article-title":"High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study.","volume":"24","author":"Bonjoch","year":"2010","journal-title":"AIDS"},{"key":"R56-1-20210130","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/QAD.0b013e32832c1792","article-title":"Continuous antiretroviral therapy decreases bone mineral density.","volume":"23","author":"Grund","year":"2009","journal-title":"AIDS"},{"key":"R57-1-20210130","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/infdis\/jir188","article-title":"Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202.","volume":"203","author":"McComsey","year":"2011","journal-title":"J Infect Dis"},{"key":"R58-1-20210130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/QAD.0b013e328328f789","article-title":"Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.","volume":"23","author":"Duvivier","year":"2009","journal-title":"AIDS"},{"key":"R59-1-20210130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1468-1293.2010.00864.x","article-title":"Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial.","volume":"12","author":"Hansen","year":"2011","journal-title":"HIV Med"},{"key":"R60-1-20210130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"R61-1-20210130","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","article-title":"Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.","volume":"51","author":"Brown","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R62-1-20210130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/QAI.0b013e31821ecf4c","article-title":"Low CD4 count is associated with an increased risk of fragility fracture in HIV-infected patients.","volume":"57","author":"Yong","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R63-1-20210130","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/QAD.0b013e3283292195","article-title":"Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.","volume":"23","author":"Collin","year":"2009","journal-title":"AIDS"},{"key":"R64-1-20210130","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1097\/QAD.0b013e32833f6294","article-title":"Fracture incidence in HIV-infected women: results from the Womens Interagency HIV Study.","volume":"24","author":"Yin","year":"2010","journal-title":"AIDS"},{"key":"R65-1-20210130","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00198-007-0428-7","article-title":"Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study.","volume":"18","author":"Prior","year":"2007","journal-title":"Osteoporos Int"},{"key":"R66-1-20210130","doi-asserted-by":"crossref","first-page":"e17217","DOI":"10.1371\/journal.pone.0017217","article-title":"Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.","volume":"6","author":"Womack","year":"2011","journal-title":"PLoS One"},{"key":"R67-1-20210130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/QAD.0b013e3280148c05","article-title":"Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.","volume":"21","author":"Arnsten","year":"2007","journal-title":"AIDS"},{"key":"R70-1-20210130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1468-1293.2008.00630.x","article-title":"The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients.","volume":"9","author":"van den Bout-van den Beukel","year":"2008","journal-title":"HIV Med"},{"key":"R72-1-20210130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.qai.0000145352.04440.1e","article-title":"Alendronate, vitamin D, and calcium for the treatment of osteopeniaosteoporosis associated with HIV infection.","volume":"38","author":"Mondy","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R73-1-20210130","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1097\/QAD.0b013e3282ef961d","article-title":"Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.","volume":"21","author":"McComsey","year":"2007","journal-title":"AIDS"},{"key":"R75-1-20210130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/fvl.11.44","article-title":"Prevention of bone loss and management of fracture risk in HIV-infected individuals: case studies and recommendations for different patient subgroups.","volume":"6","author":"Post","year":"2011","journal-title":"Future Virol"},{"key":"R78-1-20210130","doi-asserted-by":"crossref","first-page":"e8770","DOI":"10.1371\/journal.pone.0008770","article-title":"Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality.","volume":"5","author":"Mehta","year":"2010","journal-title":"PLoS One"},{"key":"R79-1-20210130","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1086\/605699","article-title":"Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania.","volume":"200","author":"Mehta","year":"2009","journal-title":"J Infect Dis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201201280-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:28:53Z","timestamp":1786048133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201201280-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,28]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32834f324b","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,28]]}}}